Business ❯ Corporate Governance
Litigation Class Action Lawsuits Securities Fraud Securities Regulation Investor Relations Legal Representation Litigation Support Litigation Risks Class Actions Lawsuits
The case centers on claims that MoonLake overstated sonelokimab’s Nanobody advantages, with the Phase 3 VELA readout undercutting those statements.